All covid-19 articles – Page 6
-
CareersChemist may become first woman in Congress with a natural science PhD
Head of the chemistry department at Stony Brook University in New York is locked in a tight race for a seat in the House of Representatives
-
Business
Covid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
News
New Covid-19 test doesn’t need reagents that are in short supply
US researchers develop a two-step test for the novel coronavirus that doesn’t requires the use of scarce reagents
-
Opinion
Chemists amid coronavirus: Pierre-Edouard Danjou
A French organic chemist says Covid-19 caused a ‘big blow’ to his research, yet he published insights gained by remote teaching chemistry
-
Opinion
Blood offering
Antibodies in various forms could bridge the Covid-19 treatment gap until a vaccine is available
-
Opinion
Jumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
Business
Covid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
Opinion
Chemists amid coronavirus: Paulette Vincent-Ruz
A chemistry education researcher at the University of Michigan finds Covid-19 has been a springboard for change in academia
-
Opinion
Chemists amid coronavirus: Philippa Ojimelukwe
A Nigerian chemist worries as her university and others in the country remain closed due to the pandemic and an academic strike
-
Business
Protein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
News
Rush to approve Covid vaccine prompted by politics may end in disaster
Push by governments to pass a vaccine without appropriate evidence could damage fight against virus
-
Business
Russian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
-
Opinion
Chemists amid coronavirus: Anton Toutov
Fuzionaire’s cofounder and chief scientist reflects on how Covid-19 has affected his growing company
-
Opinion
Chemists amid coronavirus: Amal Amin
An Egyptian polymer chemist and activist for equality in science struggles with interactive activities moving online during the pandemic
-
Business
Drop in plasma donations hits immunoglobulin supply
Lockdown and social distancing have discouraged donors, and the potential impact of convalescent plasma collection for Covid-19 treatment is unclear
-
Business
Uncovering the sources of contaminated sanitisers
Methanol and 1-propanol could get into hand gels by unintentional or deliberate adulteration
-
Opinion
Chemists amid coronavirus: Hannah Beska
A teaching technician in England is helping to make her labs safe for the start of term in September
-
Opinion
Facing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
Business
Russian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
Opinion
Chemists amid coronavirus: Anya Gryn’ova
The computational chemist has returned to her Heidelberg research institute after months of lockdown, and is thankful to be living in Germany
